Eliprodil is a non-competitive NMDA receptor antagonists which has been shown to inhibit neuronal Ca2+ channel currents.Both ifenprodil and eliprodil protect against ischaemia-induced neurodegeneration when administered post-occlusion and that they also block N and P-type voltage-dependent Ca2+ channels.Eliprodil significantly decreased the amplitude of rapid component of the delayed rectifier potassium current (I(Kr)), but slow component (I(Ks)), transient outward current (I(to)) and I(K1) were not considerably affected by the compound when measured in dog ventricular myocytes by applying the whole-cell configuration of the patch-clamp technique.eliprodil, under normal conditions, moderately lengthens cardiac repolarisation by inhibition of I(Kr). However, after the attenuation of the normal 'repolarisation reserve', this compound can induce marked QT interval prolongation, which may result in proarrhythmic action.